Exchange (NYSE) this week as ONVO shares began trading on the NYSE on Thursday, July 11, 2013, after qualifying as an NYSE MKT listing company. "Organovo is proud to ring the opening bell on behalf of our employees, investors and all of our supporters, in recognition of our recent uplisting to the New York Stock Exchange. This milestone is another important step forward for the company in our mission to advance the impact of 3D bioprinting in changing the shape of medical research and practice," said Keith Murphy
, president and chief executive officer of Organovo Holdings, Inc. "We found NYSE to have made an unparalleled commitment to providing a fertile platform for growth to early stage biotechnology companies, and we look forward to a great future on the exchange."
MiMedx Group, Inc. (MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced this week that the Company will slightly exceed the $13.5 million high end of its previously communicated revenue range for the second quarter of 2013. The Company's second quarter of 2013 revenue represents an increase of greater than 175% over second quarter of 2012 revenue, and for the six months ended June 30, 2013, MiMedx revenue increased by more than 190% over its revenue for the first six months of 2012. The Company reported that the second quarter of 2013 marks the 7th consecutive quarter in which MiMedx has met or exceeded its revenue guidance.
Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexesPage: 1 2 3 4 5 6 Related biology technology :1
. TriMix for Travel Now Available at KRS Global Biotechnology2
. Chief Medical Officer Summit for Biotechs Goes West3
. PROLOR Biotech To Present New Data On Its Long-Acting Human Growth Hormone And Long-Acting Oxyntomodulin At ENDO 20134
. Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund5
. MedReps.com Report Shows Biotech Workers Earn the Most in Medical Sales6
. Biotechnology Master’s at UMBC Shady Grove - Virtual Info Session to Be Held on June 267
. Verenium To Sponsor And Present At The 2013 Bio World Congress On Industrial Biotechnology8
. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference9
. BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries10
. NW Bios Dr. Marnix Bosch To Present At Brain Tumor Biotech Summit In New York11
. Heptares to Present at Upcoming Biotech Industry Conferences